(Q43232039)

English

Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate

scientific article published in December 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

1 reference

based on heuristic

inferred from title

Eloisa Dutra Caldas

2

object named as

Eloisa Dutra Caldas

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

author name string

Diana Brito da Justa Neves

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Raimunda Nonato Ribeiro Sampaio

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Tropical Medicine and International Health

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

1515-1522

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Determination of antimony in human blood with inductively coupled plasma-mass spectrometry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Chemotherapy of leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair. Reference values

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

The pharmacology of leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2009.02408.X

21 January 2018

Identifiers

10.1111/J.1365-3156.2009.02408.X

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43232039&oldid=1984381832"